FAQs
FAQs
There are several online resources to learn more about lymphoma and your options, from advocacy groups to research foundations. If you would like to learn more, please take a look at some of the resources listed below.
- The Lymphoma Support Network
- Leukemia and Lymphoma Society
- CancerCare
- American Cancer Society
- Lymphoma Research Foundation
- Lymphoma Coalition
- Patients – European Cancer Organisation
- C101 – A Unique Resource for People with Cancer
A lymphoma diagnosis can be overwhelming – it’s important to find support. If you would like additional information about dealing with depression and anxiety associated with your diagnosis, please take a look at these additional resources.
A clinical research study is a scientific investigation conducted in human volunteers to answer specific health questions. Interventional studies determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Clinical research studies are also called clinical trials.
The OLYMPIA studies are clinical research studies for people with lymphoma. The OLYMPIA studies seek to evaluate the efficacy and safety of an investigational drug in treating lymphoma compared to other treatments already approved for lymphoma.
Clinical studies are essential to investigating potential treatments. Living with lymphoma, you may feel that you have enough to do without committing to a clinical study. However, everyone involved in these clinical studies plays an important role in increasing our understanding of lymphoma, which may help others with this condition in the future. Every treatment that exists today is available because of people who previously took part in research studies.
Eligibility will differ based on which OLYMPIA study you join. To find out if you may be eligible, please fill out a pre-screener questionnaire. Learn more about the OLYMPIA trials to find out if you may be eligible.
Learn more
If you join the study, there are certain things you will be expected to do. This includes attending study visits and undergoing certain assessments and procedures such as imaging scans, biopsies, and blood draws. The length of your participation will depend on which of the OLYMPIA studies you participate in and your response to the study drugs.
The length of your participation will depend on several factors, including which study you participate in and your response to the study drug.
You may benefit from additional check-ups on top of your regular care, and you may have access to lymphoma specialists. There is no guarantee that you will receive a medical benefit from participating in this study. Your condition may get better, stay the same, or may even get worse.
As with all drugs, there are possible risks when taking them. You will be provided with an Informed Consent Form that will explain the risks that have been seen in other clinical studies researching the investigational study drug. It is also possible that the drug may affect you in unknown ways. If you should experience any changes in your health, however unrelated you think they may be, you should tell your study doctor and study team.
The OLYMPIA studies are taking place at study centers worldwide. Learn more about the OLYMPIA studies to find out which study center is closest to you.
Learn more

What do I do if I have other
questions?
If you have more questions about the OLYMPIA studies, please contact the site closest to you. Find out which site is closest by using our site finder tool.
Learn more